Benitec Biopharma (BNTC) Shares Outstanding (Weighted Average) (2019 - 2025)

Benitec Biopharma has disclosed Shares Outstanding (Weighted Average) across 7 years of filings, most recently posting $46.0 million for Q4 2025.

• Shares Outstanding (Weighted Average) for Q4 2025 came in at $46.0 million, up 23.39% year-over-year; the trailing twelve-month figure through Dec 2025 was $46.0 million (up 23.39% YoY), and the FY2025 annual result was $36.2 million, up 97.17% from the prior year.
• Shares Outstanding (Weighted Average) came in at $46.0 million for Q4 2025 at Benitec Biopharma, up from $41.5 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $46.0 million in Q4 2025 to a low of $6300.0 in Q2 2022.
• The 5-year median for Shares Outstanding (Weighted Average) is $13.2 million (2021), against an average of $18.8 million.
• Across the five-year window, Shares Outstanding (Weighted Average) tumbled 99.85% in 2022 and jumped 37170.46% in 2023, its largest moves.
• Benitec Biopharma's Shares Outstanding (Weighted Average) stood at $107095.0 in 2021, then soared by 1413.87% to $1.6 million in 2022, then soared by 58.91% to $2.6 million in 2023, then surged by 1346.03% to $37.3 million in 2024, then rose by 23.39% to $46.0 million in 2025.
• The last three Shares Outstanding (Weighted Average) figures came in at $46.0 million (Q4 2025), $41.5 million (Q3 2025), and $36.2 million (Q2 2025), per Business Quant data.